Literature DB >> 21558331

Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy.

Giuseppe Boriani1, Maurizio Gasparini, Maurizio Landolina, Maurizio Lunati, Alessandro Proclemer, Gabriele Lonardi, Saverio Iacopino, Werner Rahue, Mauro Biffi, Paola DiStefano, Andrea Grammatico, Massimo Santini.   

Abstract

AIMS: Uncontrolled ventricular rate (VR) during atrial fibrillation (AF) may cause clinical deterioration in heart failure (HF) patients who need continuous biventricular pacing to achieve cardiac resynchronization therapy (CRT). We aimed at evaluating the association between AF, uncontrolled VR, and sub-optimal CRT, defined as low biventricular pacing percentage (BIVP%). METHODS AND
RESULTS: All 1404 patients had HF, New York Heart Association (NYHA) ≥II, left ventricular ejection fraction (LVEF) ≤35%, and QRS ≥120 ms, and received an implantable CRT defibrillator (CRT-D). Occurrence of AF, VR during AF and lifetime BIVP% were estimated from device data. Ventricular rate during AF was defined as uncontrolled in patients with mean VR>80 bpm and maximum VR>110 bpm. Over a median follow-up of 18 months, AF was detected in 443 of 1404 patients (32%). In this sub-group of AF patients, VR during AF was uncontrolled in 150 of 443 patients (34%). Multivariate Cox regression analysis showed that age [hazard ratio (HR) = 1.03, 95% confidence interval (CI) = 1.00-1.06, P= 0.028], and uncontrolled VR [HR = 1.69 (CI = 1.01-2.83), P= 0.046] were the only independent predictors of clinical outcome, assessed by HF hospitalizations and death. The median lifetime BIVP% was 95% (25-75 percentile range 91-99%). Biventricular pacing percentage was significantly and inversely correlated to VR, decreasing by 7% for each 10 bpm increase in VR. Sub-optimal CRT, defined as BIVP% <95%, was predicted by the occurrence of persistent or permanent AF [odds ratio (OR) = 3.77, CI = 2.44-5.82, P< 0.001], and uncontrolled VR [OR = 2.25, CI = 1.35-3.73, P= 0.002].
CONCLUSION: Uncontrolled VR occurs in one-third of CRT-D patients, who experience AF, and is associated with HF hospitalizations and death and with sub-optimal CRT (lifetime BIVP%<95%).

Entities:  

Mesh:

Year:  2011        PMID: 21558331     DOI: 10.1093/eurjhf/hfr046

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  14 in total

Review 1.  ICD programming.

Authors:  Mauro Biffi
Journal:  Indian Heart J       Date:  2013-12-20

Review 2.  Rate Control in Atrial Fibrillation: Methods for Assessment, Targets for Ventricular Rate during AF, and Clinical Relevance for Device Therapy.

Authors:  Shantanu Sarkar; Paul D Ziegler
Journal:  J Atr Fibrillation       Date:  2013-06-30

3.  Atrial fibrillation-induced tachycardiomyopathy and heart failure: an underappreciated and elusive condition.

Authors:  Antonis S Manolis; Theodora A Manolis; Antonis A Manolis; Helen Melita
Journal:  Heart Fail Rev       Date:  2022-03-23       Impact factor: 4.654

4.  Comparison of partners-heart failure algorithm vs care alert in remote heart failure management.

Authors:  Leonardo Calo'; Annamaria Martino; Claudia Tota; Alessandro Fagagnini; Renzo Iulianella; Marco Rebecchi; Luigi Sciarra; Giuseppe Giunta; Maria Grazia Romano; Roberto Colaceci; Antonio Ciccaglioni; Fabrizio Ammirati; Ermenegildo de Ruvo
Journal:  World J Cardiol       Date:  2015-12-26

5.  Combined management of atrial fibrillation and heart failure: case studies.

Authors:  Frederik H Verbrugge; Wilfried Mullens
Journal:  Heart Fail Rev       Date:  2014-05       Impact factor: 4.214

Review 6.  Cardiac Resynchronization in Patients with Atrial Fibrillation.

Authors:  S Serge Barold; Bengt Herweg
Journal:  J Atr Fibrillation       Date:  2015-12-31

Review 7.  Co-Morbidities and Cardiac Resynchronization Therapy: When Should They Modify Patient Selection?

Authors:  Martin H Ruwald
Journal:  J Atr Fibrillation       Date:  2015-06-30

8.  Atrial fibrillation in patients with systolic heart failure: pathophysiology mechanisms and management.

Authors:  Ioanna Koniari; Eleni Artopoulou; Dimitrios Velissaris; Nicholas Kounis; Grigorios Tsigkas
Journal:  J Geriatr Cardiol       Date:  2021-05-28       Impact factor: 3.327

Review 9.  Atrial fibrillation in heart failure: what should we do?

Authors:  Dipak Kotecha; Jonathan P Piccini
Journal:  Eur Heart J       Date:  2015-09-28       Impact factor: 29.983

10.  The MOnitoring Resynchronization dEvices and CARdiac patiEnts (MORE-CARE) randomized controlled trial: phase 1 results on dynamics of early intervention with remote monitoring.

Authors:  Giuseppe Boriani; Antoine Da Costa; Renato Pietro Ricci; Aurelio Quesada; Stefano Favale; Saverio Iacopino; Francesco Romeo; Arnaldo Risi; Lorenza Mangoni di S Stefano; Xavier Navarro; Mauro Biffi; Massimo Santini; Haran Burri
Journal:  J Med Internet Res       Date:  2013-08-21       Impact factor: 5.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.